Clinical trial
BIOTRONIK- Pharmacokinetic Study of a Sirolimus Derivative-Coated Balloon (BRight DCB) in the Superficial Femoral and Proximal Popliteal Artery
NCT06065345 is registered in ClinicalTrials.gov with Biotronik CRC Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BIOTRONIK- Pharmacokinetic Study of a Sirolimus Derivative-Coated Balloon (BRight DCB) in the Superficial Femoral and Proximal Popliteal Artery
- Lead sponsor
- Biotronik CRC Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2024
- Completion date
- July 22, 2025
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral artery disease